Gasless laparoscopic surgery for ulcerative colitis and familial adenomatous polyposis

2003 ◽  
Vol 17 (6) ◽  
pp. 899-902 ◽  
Author(s):  
H. Ishida ◽  
D. Hashimoto ◽  
S. Inokuma ◽  
H. Nakada ◽  
T. Ohsawa ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Laparoscopic Surgery ◽  
Familial Adenomatous Polyposis ◽  
Adenomatous Polyposis

The Ileo Neo-Rectal Anastomosis, a restorative procedure for ulcerative colitis and familial adenomatous polyposis without a pouch

2000 ◽  
Vol 118 (4) ◽  
pp. A118
Author(s):  
Cees J. Laarhoven ◽  
Gunnar I. Andriesse ◽  
Marguerite E. Schipper ◽  
Louis M. Akkermans ◽  
Theo J. Vroonhoven ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Familial Adenomatous Polyposis ◽  
Adenomatous Polyposis ◽  
Rectal Anastomosis

scholarly journals Restorative Proctocolectomy: When to Propose and When to Avoid

2021 ◽  
Author(s):  
Marisa D. Santos
Keyword(s):  
Ulcerative Colitis ◽  
Familial Adenomatous Polyposis ◽  
Restorative Proctocolectomy ◽  
Ileal Pouch ◽  
Adenomatous Polyposis ◽  
Entire Colon ◽  
Anal Anastomosis ◽  
Colon And Rectum ◽  
Complex Surgery ◽  
Over Time

Restorative proctocolectomy with ileal pouch-anal anastomosis (RPC-IPAA) is a surgical procedure performed when excising the entire colon and rectum is need and reconstitution of the intestinal transit through an ileal pouch is made with anastomosis to the anus. It is mainly used to treat patients with familial adenomatous polyposis (FAP) and ulcerative colitis (UC). It is a complex surgery with potential complications, and the functional outcomes can be worse over time. So, it is essential to select the appropriate patient, proceed to a correct surgical technique, and know-how to deal with and solve the main ileal pouch complications. This chapter intends to be a reflection on this subject.

Utility of Mesalazine in Familial Adenomatous Polyposis: Clinical Report of Reduction of Polyp Size in Patients with Ulcerative Colitis, and Safety Examination in Familial Adenomatous Polyposis Patients

Pharmacology ◽  
2019 ◽  
Vol 104 (1-2) ◽  
pp. 51-56 ◽  
Author(s):  
Hideki Ishikawa ◽  
Michihiro Mutoh ◽  
Takashi Abe ◽  
Takeshi Nakajima ◽  
Yoji Takeuchi ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Familial Adenomatous Polyposis ◽  
High Dose ◽  
Clinical Report ◽  
Colon Polyps ◽  
Adenomatous Polyposis ◽  
Polyp Size ◽  
Double Blind ◽  
Standard Drug ◽  
Intestinal Polyp

Mesalazine is the gold standard drug for treatment of ulcerative colitis (UC). Here, we describe 4 cases of familial adenomatous polyposis (FAP) patients with UC that showed reduction of intestinal polyp diameter by mesalazine treatment. Of note, the effects of mesalazine on the development of intestinal polyps in FAP patients have not been reported, and we further investigated whether the short-term use of high-dose mesalazine (4 g/day) has harmful effects on FAP patients or not. The authors found that the treatment showed slightly adverse events in FAP patients. However, mesalazine tended to reduce the number of colon polyps in male subjects with FAP. This report provides basic information for planning a double-blind, randomized, clinical trial that aims to show mesalazine’s potential to suppress intestinal polyp development in FAP.

scholarly journals Salvage surgery after restorative proctocolectomy

2004 ◽  
Vol 51 (2) ◽  
pp. 23-26
Author(s):  
R.J. Nicholls
Keyword(s):  
Ulcerative Colitis ◽  
Familial Adenomatous Polyposis ◽  
Restorative Proctocolectomy ◽  
Salvage Surgery ◽  
Rectal Mucosa ◽  
Neoplastic Transformation ◽  
Mucosal Inflammation ◽  
Adenomatous Polyposis ◽  
Elective Surgical Procedure ◽  
Causes Of Failure

Restorative proctocolectomy is now the elective surgical procedure of choice for most patients with ulcerative colitis or familial adenomatous polyposis. There are four causes of failure including acute and chronic sepsis, poor function for mechanical or functional reasons, mucosal inflammation (including pouchitis and retained rectal mucosa) and neoplastic transformation. Failure rates themselves range from 5% to nearly 20%. Followed over a period of 20 years, the failure rate can be summarised approximately as 5% at five years, 10% at ten years and 15% at 15 years.

Sign in / Sign up

Export Citation Format

Share Document